Reducing Cardiovascular Risk With Effective Management Of LDL Cholesterol - A Round Table Discussion

Published: 18 December 2020

  • Views:

    Views Icon 79
  • Likes:

    Heart Icon 7
  • episode_image
    2m 29s
    Part 6 Chapter 6: Summary
    Kausik (Kosh) Ray, Lale Tokgözoğlu, Christie Ballantyne
Average (ratings)
No ratings
Your rating

Overview

This round table is designed to provide clinicians with a better understanding of the long-term CV risks of LDL-C exposure. In addition to reviewing the pathogenesis of atherosclerosis and assessing the long term implications of elevated LDL-C, this meeting will consider current guidance around controlling LDL-C, the challenges in achieving LDL-C targets, and evaluate how emerging strategies are contributing to LDL-C management.

 

Each chapter will comprise of a short presentation by the named medical expert followed by a panel discussion amongst all faculty.

This medical experts round table discussion was organised independently by Radcliffe Cardiology, work that was funded by Novartis. It is intended for healthcare professionals as medical educational material, and may include data/information on investigational uses of compounds/drugs that have not yet been approved by regulatory authorities.

Learning objectives

  • Outline the pathogenic nature and clinical risk of extended exposure to elevated LDL-C
  • Describe the clinical challenges in achieving guideline-based LDL-C goals
  • Compare and contrast LDL-C lowering therapies

More from this programme

Part 1

Chapter 1: Welcome and introductions

Part 2

Chapter 2: The role of long-term exposure to elevated LDL-C in the pathogenesis of atherosclerosis and clinical risk

Part 3

Chapter 3: Current approaches to controlling LDL-C – what do the guidelines say?

Part 4

Chapter 4: Challenges in achieving guideline-based LDL-C targets in the real world

Part 5

Chapter 5: Contemporary approaches to managing LDL-C and cardiovascular risk

Part 6

Chapter 6: Summary

Faculty Biographies